Durvalumab in Patients With HER-2 Positive Metastatic Breast Cancer Receiving Trastuzumab
Clinical trial NCT02649686 · COMPLETED
Trial details
- NCT number
- NCT02649686
- Sponsor
- Canadian Cancer Trials Group
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-17
- Primary completion
- 2017-09-25
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.